High preoperative white blood cell count determines poor prognosis and is associated with an immunosuppressive microenvironment in colorectal cancer

Abstract

BackgroundThe correlation between high white blood cell (WBC) count and poor prognosis has been identified in various types of cancer; however, the clinical significance and immune context of WBC count in colorectal cancer remains unclear.MethodsBetween February 2009 and November 2014, 7,433 patients at the Shanghai Cancer Center who had undergone elective surgery for colorectal cancer were enrolled in this retrospective cohort study. Patients were divided into two groups: low and high preoperative WBC groups. Propensity score matching was used to address the differences in baseline characteristics. The Kaplan–Meier method and Cox regression analysis were used to identify independent prognostic factors in colorectal cancer patients. Tumor-infiltrating immune cells in the high and low preoperative WBC groups were compared using immunohistochemical staining.ResultsOf the 7,433 patients who underwent colorectal cancer surgery and were available for analysis, 5,750 were included in the low preoperative WBC group, and 1,683 were included in the high preoperative WBC group. After propensity score matching, 1,553 patients were included in each group. Kaplan–Meier survival curves showed that a high preoperative WBC count was associated with a decreased overall survival (P = 0.002) and disease-free survival (P = 0.003), and that preoperative WBC count was an independent risk factor for overall survival (hazard ratio, 1.234; 95% confidence interval, 1.068–1.426; P = 0.004) and disease-free survival (hazard ratio, 1.210; 95% confidence interval, 1.047–1.397, P = 0.01). Compared to the low preoperative WBC group, the high preoperative WBC group exhibited higher expression of regulatory T cells (P = 0.0034), CD68+ macrophages (P = 0.0071), and CD66b+ neutrophils (P = 0.0041); increased expression of programmed cell death protein 1 (P = 0.005) and programmed cell death ligand 1 (P = 0.0019); and lower expression of CD8+ T cells (P = 0.0057) in colorectal cancer patients.ConclusionsOur research indicates that a high preoperative WBC count is a prognostic indicator in colorectal cancer patients and is associated with an immunosuppressive tumor microenvironment, which could aid in future risk stratification.

The characteristic and prognostic role of blood inflammatory markers in patients with Huntington’s disease from China

“…The multivariable Cox regression analysis showed that a higher WBC count and monocyte counts were significantly correlated with an increased risk of disability and mortality among patients with HD. Elevated total WBC count and monocyte count have been reported to be a significant indicator of reduced survival in patients with cardiovascular disease ( 52 ) and cancer ( 53 ), showing a positive correlation with all-cause mortality ( 54 ). This is the first study to demonstrate an association between higher WBC count and monocyte and HD prognosis.…”

Nomogram-based prognostic tool for stage IIIB/IV non-small cell lung cancer patients undergoing traditional Chinese medicine treatment

“…In the present study, we found that WBCs, an inflammatory factor, play a crucial role in the development, growth, infiltration, and spread of tumors. As a result, WBC counts in patients with advanced NSCLC have been shown to have predictive value for prognosis when undergoing immunotherapy [ 27 , 28 ]. Moreover, most studies have consistently demonstrated that baseline WBC count exhibits a greater predictive capacity [ 29 , 30 ].…”

Can Routine Laboratory Tests Be Suggestive in Determining Suspicions of Malignancy in the Case of Thyroid Nodules?

“…The white blood cell (WBC) count is an important laboratory parameter that reflects the body’s immune response and inflammatory status. In the context of thyroid nodules, alterations in WBC count have been investigated as a potential marker for distinguishing between benign and malignant thyroid cancer [ 23 , 24 ].…”